Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Simcere Pharmaceutical Group Limited ( (HK:2096) ) is now available.
Simcere Pharmaceutical Group Limited has announced its upcoming annual general meeting scheduled for June 13, 2025, in Shanghai. Key agenda items include the adoption of the 2024 financial statements, declaration of a final dividend, re-election of directors, and re-appointment of KPMG as auditors. The meeting will also consider granting the directors authority to issue additional shares, which could impact the company’s capital structure and shareholder value.
The most recent analyst rating on (HK:2096) stock is a Buy with a HK$8.20 price target. To see the full list of analyst forecasts on Simcere Pharmaceutical Group Limited stock, see the HK:2096 Stock Forecast page.
More about Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating within the pharmaceutical industry. It focuses on the development, production, and distribution of pharmaceutical products, with a market emphasis on innovative drugs and treatments.
Average Trading Volume: 8,127,981
Technical Sentiment Signal: Buy
Current Market Cap: HK$24.42B
For detailed information about 2096 stock, go to TipRanks’ Stock Analysis page.